Dawn Peck

1.1k total citations
32 papers, 607 citations indexed

About

Dawn Peck is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Dawn Peck has authored 32 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Biochemistry, 13 papers in Molecular Biology and 13 papers in Physiology. Recurrent topics in Dawn Peck's work include Metabolism and Genetic Disorders (16 papers), Lysosomal Storage Disorders Research (10 papers) and Mitochondrial Function and Pathology (7 papers). Dawn Peck is often cited by papers focused on Metabolism and Genetic Disorders (16 papers), Lysosomal Storage Disorders Research (10 papers) and Mitochondrial Function and Pathology (7 papers). Dawn Peck collaborates with scholars based in United States, United Kingdom and Canada. Dawn Peck's co-authors include Shawn E. Christ, Amanda J. Moffitt, Desirée A. White, Dimitar Gavrilov, Huiling Peng, Kimberly E. Bodner, Dietrich Matern, Dawn A. Laney, Linda Manwaring and Devin Oglesbee and has published in prestigious journals such as Mayo Clinic Proceedings, Genetics in Medicine and International Journal of Cardiology.

In The Last Decade

Dawn Peck

30 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn Peck United States 13 329 320 287 85 79 32 607
Hélène Ogier France 13 443 1.3× 292 0.9× 415 1.4× 113 1.3× 109 1.4× 16 877
Joyce A. Kobori United States 11 277 0.8× 329 1.0× 234 0.8× 178 2.1× 113 1.4× 14 686
Gerard De Jong Australia 11 235 0.7× 256 0.8× 139 0.5× 150 1.8× 50 0.6× 19 592
Alexander Broomfield United Kingdom 14 205 0.6× 358 1.1× 140 0.5× 137 1.6× 124 1.6× 54 613
Lock Hock Ngu Malaysia 18 503 1.5× 181 0.6× 299 1.0× 113 1.3× 90 1.1× 59 899
Annette S. Feigenbaum Canada 11 374 1.1× 257 0.8× 387 1.3× 87 1.0× 39 0.5× 13 620
Kendra Bjoraker United States 11 158 0.5× 315 1.0× 133 0.5× 88 1.0× 90 1.1× 18 536
Annette Bley Germany 14 500 1.5× 349 1.1× 115 0.4× 34 0.4× 144 1.8× 29 816
Ana Marcão Portugal 12 188 0.6× 402 1.3× 159 0.6× 160 1.9× 169 2.1× 22 616
Shlomo Almashanu Israel 16 390 1.2× 128 0.4× 271 0.9× 67 0.8× 62 0.8× 45 838

Countries citing papers authored by Dawn Peck

Since Specialization
Citations

This map shows the geographic impact of Dawn Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Peck more than expected).

Fields of papers citing papers by Dawn Peck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Peck. The network helps show where Dawn Peck may publish in the future.

Co-authorship network of co-authors of Dawn Peck

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Peck. A scholar is included among the top collaborators of Dawn Peck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Peck. Dawn Peck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Patricia, Amy White, Dawn Peck, et al.. (2025). Two-tiered newborn screening for infantile Krabbe disease allows timely treatment initiation and avoids false-positive results. Genetics in Medicine. 101572–101572.
2.
Turgeon, Coleman, Kari Casas, Ryan Flanagan, et al.. (2024). Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase. Molecular Genetics and Metabolism Reports. 40. 101110–101110. 1 indexed citations
3.
White, Amy, Dawn Peck, Dimitar Gavrilov, et al.. (2024). Sensitivity of transferrin isoform analysis for PMM2-CDG. Molecular Genetics and Metabolism. 143(1-2). 108564–108564. 1 indexed citations
4.
Laney, Dawn A., Dawn Peck, Andrea M. Atherton, et al.. (2024). Prospective characterization of early symptom onset and progression in young pediatric patients with variants in the GLA gene across 5 years: Longitudinal data from the Fabry MOPPet Study. Genetics in Medicine Open. 2. 101891–101891. 1 indexed citations
5.
Peck, Dawn, Jean M. Lacey, Amy White, et al.. (2020). Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. International Journal of Neonatal Screening. 6(1). 10–10. 28 indexed citations
6.
Aldridge, Kristina, et al.. (2020). The effects of early-treated phenylketonuria on volumetric measures of the cerebellum. Molecular Genetics and Metabolism Reports. 25. 100647–100647. 11 indexed citations
7.
Conboy, Erin, Silvia Tortorelli, Kim K. Nickander, et al.. (2019). Multiplex testing for the screening of lysosomal storage disease in urine: Sulfatides and glycosaminoglycan profiles in 40 cases of sulfatiduria. Molecular Genetics and Metabolism. 129(2). 106–110. 10 indexed citations
8.
Miranda, William R., et al.. (2019). Surgical septal myectomy for relief of dynamic obstruction in Anderson-Fabry Disease. International Journal of Cardiology. 292. 91–94. 10 indexed citations
9.
Peck, Dawn, Jean M. Lacey, Coleman Turgeon, et al.. (2017). Precision newborn screening for lysosomal disorders. Genetics in Medicine. 20(8). 847–854. 95 indexed citations
10.
Christ, Shawn E., et al.. (2016). Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria. Molecular Genetics and Metabolism. 118(1). 3–8. 31 indexed citations
11.
Govindarajan, Raghav, et al.. (2016). Response to letter to the editor: Why does Leigh syndrome responds to immunotherapy?. Molecular Genetics and Metabolism Reports. 8. 85–86. 1 indexed citations
12.
Govindarajan, Raghav, et al.. (2016). Response to immunotherapy in a patient with adult onset Leigh syndrome and T9176C mtDNA mutation. Molecular Genetics and Metabolism Reports. 8. 28–32. 12 indexed citations
13.
Laney, Dawn A., Dawn Peck, Andrea M. Atherton, et al.. (2014). Fabry disease in infancy and early childhood: a systematic literature review. Genetics in Medicine. 17(5). 323–330. 68 indexed citations
14.
Christ, Shawn E., Amanda J. Moffitt, Dawn Peck, & Desirée A. White. (2013). The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria. NeuroImage Clinical. 3. 539–547. 45 indexed citations
15.
Bodner, Kimberly E., Kristina Aldridge, Amanda J. Moffitt, et al.. (2012). A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria. Molecular Genetics and Metabolism. 107(3). 302–307. 23 indexed citations
16.
Therrell, Bradford L., Marie Y. Mann, Carolyn S. Anderson, et al.. (2011). Tracking clinical genetic services for newborns identified through newborn dried bloodspot screening in the United States—lessons learned. Journal of Community Genetics. 2(4). 191–200. 5 indexed citations
17.
Carleton, Stephanie M., et al.. (2010). DNA Carrier Testing and Newborn Screening for Maple Syrup Urine Disease in Old Order Mennonite Communities. Genetic Testing and Molecular Biomarkers. 14(2). 205–208. 8 indexed citations
18.
Christ, Shawn E., Amanda J. Moffitt, & Dawn Peck. (2009). Disruption of prefrontal function and connectivity in individuals with phenylketonuria☆. Molecular Genetics and Metabolism. 99. S33–S40. 37 indexed citations
19.
He, Qing, Shawn E. Christ, Kevin Karsch, et al.. (2009). Detecting 3D Corpus Callosum abnormalities in phenylketonuria. International Journal of Computational Biology and Drug Design. 2(4). 289–289. 8 indexed citations
20.
Gripp, Karen W., Angela E. Lin, Linda K. Nicholson, et al.. (2007). Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio‐facio‐cutaneous syndrome from Costello syndrome. American Journal of Medical Genetics Part A. 143A(13). 1472–1480. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Ogier Breakdown of academic impact, for papers by Joyce A. Kobori Breakdown of academic impact, for papers by Gerard De Jong Breakdown of academic impact, for papers by Alexander Broomfield Breakdown of academic impact, for papers by Lock Hock Ngu Breakdown of academic impact, for papers by Annette S. Feigenbaum Breakdown of academic impact, for papers by Kendra Bjoraker Breakdown of academic impact, for papers by Annette Bley Breakdown of academic impact, for papers by Ana Marcão Breakdown of academic impact, for papers by Shlomo Almashanu
Rankless by CCL
2026